№ lp_2_2_02825
File format: docx
Character count: 15077
File size: 94 KB
This document outlines the training and assessment requirements for orthoptists in administering botulinum toxin injections within an ophthalmology-led clinic for treating hemifacial spasm and blepharospasm.
Year:
Not specified
Region / City:
Not specified
Subject:
Ophthalmology, Botulinum Toxin Therapy
Document Type:
Training Document
Organization:
Not specified
Author:
Not specified
Target Audience:
Orthoptists seeking training in botulinum toxin injections
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Organization:
STATDDS
Associated Organizations:
Merz; Allergan; Henry Schein; AAFE; BD
Products Mentioned:
Xeomin; Belotero Balance; Radiesse; Botox; Juvederm; Voluma; Comfortox Syringes; Bacteriostatic 0.9% Sodium Chloride; Alcohol Prep Pads
Document Type:
Product and Ordering Information Sheet
Industry:
Medical and Dental Aesthetics
Intended Audience:
Dental Professionals; Medical Professionals; Clinicians
Distribution Information:
Exclusive dental distribution of specified products by STATDDS
Contact Information:
800-693-9076; [email protected]
Note:
; 866-862-1211; 800-347-4500
Website:
STATDDS.com
Supplies Covered:
Syringes for reconstitution and injection; starter kits; bacteriostatic saline; ice packs; sterile needles
Packaging Details:
Individual sterile packaging; box quantities; vial quantities
Order References:
Henry Schein Order #890-8538; #104-6851; #987-8204; #987-1329
Year:
2026
Region / City:
University of Washington
Theme:
Select Toxin Transfer, Due Diligence
Document Type:
Form
Organization / Institution:
University of Washington, Environmental Health & Safety
Author:
Not specified
Target Audience:
Researchers, Laboratory Personnel
Period of Validity:
Indefinite
Approval Date:
Not specified
Date of Amendments:
Not specified
Note:
Year
Topic:
Diphtheria Toxin Handling and Safety Protocol
Document Type:
Standard Operating Procedure
Target Audience:
Researchers, Laboratory Personnel
Year:
2026
Institution:
Duke University
Document Type:
Standard Operating Procedure (SOP)
Subject:
Pertussis toxin handling and safety
Author:
Not specified
Approval:
OESO SOP Approval Date provided
Intended Audience:
Laboratory personnel working with pertussis toxin
Hazard Classification:
Acute toxicity (oral, inhalation, dermal), eye irritation
Biosafety Level:
BSL-2 precautions recommended
Storage Conditions:
4°C in original container, secondary shatterproof container
Preparation Area:
Class II Biological Safety Cabinet (BSC) or Chemical Fume Hood (CFH)
Routes of Exposure:
Skin, inhalation, ingestion, injection
Emergency Procedures:
First aid and exposure response protocols specified
Year:
2023
Region / City:
Berkeley, CA
Topic:
Biosafety, Laboratory Procedures, Toxicology
Document Type:
Standard Operating Procedure (SOP)
Institution:
University of California, Berkeley
Author:
EH&S
Target Audience:
Researchers, Laboratory Personnel, Biosafety Officers
Period of Validity:
Ongoing
Approval Date:
2023
Amendment Date:
Not provided
Document Type:
Administrative form and procedural guideline
Subject:
Destruction of Select Agent Toxins
Regulatory Reference:
42 CFR 73.7(h); 42 CFR 73.21
Responsible Office:
Environmental Health and Safety (EH&S)
Related Authority:
U.S. Department of Health and Human Services
Applicable To:
Principal Investigators and laboratory personnel handling Select Agents or Toxins
Destruction Methods:
Chemical inactivation (sodium hypochlorite); autoclave heat treatment
Safety Requirements:
Laboratory hood or biological safety cabinet; specified personal protective equipment
Notification Requirement:
Written notice five business days prior to destruction
Witness Requirement:
EH&S staff member
Disposal Procedure:
Collection and disposal by Environmental Health and Safety
Contact Information:
Biosafety Office 928-523-7268
Organization:
STATDDS
Associated Organizations:
Merz; Allergan; Henry Schein; AAFE; BD
Products Mentioned:
Xeomin; Belotero Balance; Radiesse; Botox; Juvederm; Voluma; Comfortox Syringes; Bacteriostatic 0.9% Sodium Chloride; Alcohol Prep Pads
Document Type:
Product and Ordering Information Sheet
Industry:
Medical and Dental Aesthetics
Intended Audience:
Dental Professionals; Medical Professionals; Clinicians
Distribution Information:
Exclusive dental distribution of specified products by STATDDS
Contact Information:
800-693-9076; [email protected]
Note:
; 866-862-1211; 800-347-4500
Website:
STATDDS.com
Supplies Covered:
Syringes for reconstitution and injection; starter kits; bacteriostatic saline; ice packs; sterile needles
Packaging Details:
Individual sterile packaging; box quantities; vial quantities
Order References:
Henry Schein Order #890-8538; #104-6851; #987-8204; #987-1329
Year:
2023
Region / City:
USA
Topic:
Biosafety, Laboratory Protocols
Document Type:
Safety Manual
Organization / Institution:
University of Southern California
Author:
Unknown
Target Audience:
Laboratory Personnel
Period of Validity:
Ongoing
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
Not specified
Institution:
University of Florida
Department / Unit:
Environmental Health and Safety (EHS)
Document Type:
Standard Operating Procedure
Topic:
Laboratory biosafety and handling of pertussis toxin in animal research
Biological Agent:
Pertussis toxin
Source Organism:
Bordetella pertussis
Animal Model:
Rodents
Responsible Role:
Principal Investigator and laboratory staff
Related Policy:
Policy on Handling Animals Exposed to Biological Hazards
Required Approval:
Animal Use Protocol (AUP)
Engineering Controls:
Animal Transfer Station (ATS), Biosafety Cabinet (BSC), Chemical Fume Hood (CFH)
Personal Protective Equipment:
Lab attire, eye protection, long-sleeve gown or dedicated lab coat, single gloves
Clear Time After Administration:
72 hours
Waste Decontamination Methods:
Autoclaving at 121°C and 15 psi for 60 minutes or chemical inactivation with sodium hypochlorite
Emergency Contacts:
Environmental Health and Safety, University Police Department, Poison Control Center
Year:
2026
Location:
United States
Subject:
Veterinary Medicine, Nephrology
Document Type:
Research Article
Institutions:
The Ohio State University; University of Georgia; Oregon State University
Authors:
Rene Paschall, Jessica Quimby, Bianca Lourenço, Stacie Summers, Chad Schmiedt
Species Studied:
Domestic Cats
Sample Size:
14
CKD Stages:
IRIS Stage 2 and 3
Treatment:
Porus® One, oral adsorbent, 500 mg daily
Study Period:
112 days
Measurements:
Serum indoxyl sulfate, p-cresyl sulfate, Doppler blood pressure, biochemistry, urinalysis, urine protein:creatinine ratio
Study Design:
Prospective cross-sectional study